These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18201873)

  • 21. Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin.
    Sader HS; Fritsche TR; Jones RN
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2330-6. PubMed ID: 16801409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiofilm Activity and Synergistic Inhibition of Staphylococcus aureus Biofilms by Bactericidal Protein P128 in Combination with Antibiotics.
    Nair S; Desai S; Poonacha N; Vipra A; Sharma U
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7280-7289. PubMed ID: 27671070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The anti-biofilm effect of macrolides in a rat model of S. aureus foreign-body infection: Might it be of clinical relevance?
    El Haj C; Murillo O; Ribera A; Garcia-Somoza D; Tubau F; Cabellos C; Cabo J; Ariza J
    Med Microbiol Immunol; 2017 Feb; 206(1):31-39. PubMed ID: 27639707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of sarA on daptomycin susceptibility of Staphylococcus aureus biofilms in vivo.
    Weiss EC; Zielinska A; Beenken KE; Spencer HJ; Daily SJ; Smeltzer MS
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4096-102. PubMed ID: 19651914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activities of vancomycin and linezolid against biofilm-producing methicillin-resistant staphylococci species isolated from catheter-related bloodstream infections from an Egyptian tertiary hospital.
    Hashem AA; Abd El Fadeal NM; Shehata AS
    J Med Microbiol; 2017 Jun; 66(6):744-752. PubMed ID: 28598310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).
    Sader HS; Watters AA; Fritsche TR; Jones RN
    BMC Infect Dis; 2007 Apr; 7():29. PubMed ID: 17442104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activities of Combinations of Antistaphylococcal Antibiotics with Fusidic Acid against Staphylococcal Biofilms in
    Siala W; Rodriguez-Villalobos H; Fernandes P; Tulkens PM; Van Bambeke F
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of azithromycin in combination with vancomycin, daptomycin, fosfomycin, tigecycline, and ceftriaxone on Staphylococcus epidermidis biofilms.
    Presterl E; Hajdu S; Lassnigg AM; Hirschl AM; Holinka J; Graninger W
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3205-10. PubMed ID: 19451280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative activity of daptomycin against clinical isolates of methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci].
    Picazo JJ; Betriu C; Rodríguez-Avial I; Culebras E; López F; Gómez M;
    Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):13-6. PubMed ID: 19406529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Antimicrobial and Physical Treatments on Growth of Multispecies Staphylococcal Biofilms.
    Stewart EJ; Payne DE; Ma TM; VanEpps JS; Boles BR; Younger JG; Solomon MJ
    Appl Environ Microbiol; 2017 Jun; 83(12):. PubMed ID: 28411222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of linezolid and vancomycin lock solutions with and without heparin against biofilm-producing bacteria.
    Luther MK; Mermel LA; LaPlante KL
    Am J Health Syst Pharm; 2017 May; 74(9):e193-e201. PubMed ID: 28438824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small Molecules Produced by Commensal Staphylococcus epidermidis Disrupt Formation of Biofilms by Staphylococcus aureus.
    Glatthardt T; Campos JCM; Chamon RC; de Sá Coimbra TF; Rocha GA; de Melo MAF; Parente TE; Lobo LA; Antunes LCM; Dos Santos KRN; Ferreira RBR
    Appl Environ Microbiol; 2020 Feb; 86(5):. PubMed ID: 31862721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin.
    Sakoulas G; Alder J; Thauvin-Eliopoulos C; Moellering RC; Eliopoulos GM
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1581-5. PubMed ID: 16569891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From Antihistamine to Anti-infective: Loratadine Inhibition of Regulatory PASTA Kinases in Staphylococci Reduces Biofilm Formation and Potentiates β-Lactam Antibiotics and Vancomycin in Resistant Strains of
    Cutrona N; Gillard K; Ulrich R; Seemann M; Miller HB; Blackledge MS
    ACS Infect Dis; 2019 Aug; 5(8):1397-1410. PubMed ID: 31132246
    [No Abstract]   [Full Text] [Related]  

  • 35. Activity of daptomycin against enterococci and coagulase-negative staphylococci (CNS): relationship between CNS susceptibility and slime production.
    Marone P; Perversi L; Navarra A; Monzillo V; Sartirana E
    J Chemother; 1993 Jun; 5(3):151-4. PubMed ID: 8396625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces.
    Wu JA; Kusuma C; Mond JJ; Kokai-Kun JF
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3407-14. PubMed ID: 14576095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New Insight into Daptomycin Bioavailability and Localization in Staphylococcus aureus Biofilms by Dynamic Fluorescence Imaging.
    Boudjemaa R; Briandet R; Revest M; Jacqueline C; Caillon J; Fontaine-Aupart MP; Steenkeste K
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4983-90. PubMed ID: 27297479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microcalorimetric detection of staphylococcal biofilm growth on various prosthetic biomaterials after exposure to daptomycin.
    Ravn C; Ferreira IS; Maiolo E; Overgaard S; Trampuz A
    J Orthop Res; 2018 Oct; 36(10):2809-2816. PubMed ID: 29744925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activity of oritavancin against community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA), vancomycin-intermediate S. aureus (VISA), vancomycin-resistant S. aureus (VRSA) and daptomycin-non-susceptible S. aureus (DNSSA).
    Saravolatz LD; Pawlak J; Johnson LB
    Int J Antimicrob Agents; 2010 Jul; 36(1):69-72. PubMed ID: 20413274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of oritavancin against biofilms of staphylococci isolated from prosthetic joint infection.
    Yan Q; Karau MJ; Patel R
    Diagn Microbiol Infect Dis; 2018 Oct; 92(2):155-157. PubMed ID: 29885758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.